Mrc1 — Mannose Receptor C Type 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MRC1 — Mannose Receptor C Type 1 | |
|---|---|
| Symbol | MRC1 |
| Full Name | Mannose Receptor C Type 1 |
| Chromosome | 10p12.33 |
| NCBI Gene | 4360 |
| Ensembl | ENSG00000138739 |
| OMIM | 607075 |
| UniProt | P22897 |
| Diseases | Alzheimer's Disease, Multiple Sclerosis, Atherosclerosis |
| Expression | Macrophages, Dendritic Cells, Microglia, Liver |
MRC1 (Mannose Receptor C Type 1) is a gene located on chromosome 10p12.33 that encodes a C-type lectin receptor involved in immune recognition and clearance of glycoproteins. Also known as CD206, MRC1 is expressed primarily on macrophages, dendritic cells, and microglia, where it mediates endocytosis and phagocytosis of target molecules.
MRC1 recognizes and clears:
In the brain, MRC1 is expressed on microglia and mediates:
Alzheimer's Disease: MRC1 (CD206) is a marker of alternative activation (M2) microglia. It may play a protective role in Aβ clearance.
Multiple Sclerosis: MRC1 expression on microglia correlates with lesion type and disease stage.
Atherosclerosis: MRC1 on macrophages promotes clearance of modified lipoproteins.
The study of Mrc1 — Mannose Receptor C Type 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.